A Phase 1/2 study of filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma

по Shah, Jatin J., Kaufman, Jonathan L., Zonder, Jeffrey A., Cohen, Adam D., Bensinger, William I., Hilder, Brandi, Rush, Selena, Walker, Duncan, Tunquist, Brian, Litwiler, Kevin, Ptaszynski, Mieke, Orlowski, Robert Z., Lonial, Sagar
Опубликовано в: Cancer (2017)

A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes

по Garcia-Manero, Guillermo, Khoury, Hanna J., Jabbour, Elias, Lancet, Jeffrey, Winski, Shannon L., Cable, LouAnn, Rush, Selena, Maloney, Lara, Hogeland, Grant, Ptaszynski, Mieke, Calvo, Monica Cabrero, Bohanan, Zach, List, Alan, Kantarjian, Hagop, Komrokji, Rami
Опубликовано в: Clin Cancer Res (2014)

A Phase 1 Dose-Escalation Study of ARRY-520, a KSP Inhibitor, in Patients with Advanced Myeloid Leukemias

по Khoury, Hanna Jean, Garcia-Manero, Guillermo, Borthakur, Gautam, Kadia, Tapan, Foudray, Maria Cielo, Arellano, Martha, Langston, Amelia, Bethelmie-Bryan, Beverly, Rush, Selena, Litwiler, Kevin, Karan, Sharon, Simmons, Heidi, Marcus, Adam I., Ptaszynski, Mieke, Kantarjian, Hagop
Опубликовано в: Cancer (2011)

A Phase 1 Dose-Escalation Study of Filanesib Plus Bortezomib and Dexamethasone in Patients With Recurrent/Refractory Multiple Myeloma

по Chari, Ajai, Htut, Myo, Zonder, Jeffrey A., Fay, Joseph W., Jakubowiak, Andrzej J., Levy, Joan B., Lau, Kenneth, Burt, Steven M., Tunquist, Brian J., Hilder, Brandi W., Rush, Selena A., Walker, Duncan H., Ptaszynski, Mieke, Kaufman, Jonathan L.
Опубликовано в: Cancer (2016)